Like virginity, investor trust is bloody difficult to get back once lost. Good news titbits now are years overdue with no short term increase in revenue in sight and THAT is the fodder for shorters and the albatross around the neck of the share price.
Ann: New case of SCENESSE efficacy in vitiligo presented at AAD, page-10
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.09 |
Change
-0.120(0.79%) |
Mkt cap ! $758.0M | |||
| Open | High | Low | Value | Volume |
| $15.20 | $15.21 | $14.90 | $529.2K | 35.02K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 52 | $15.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.10 | 168 | 11 |
View Market Depth
| Last trade - 15.53pm 13/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$15.14 |
Change
-0.120 ( 0.16 %) |
||||
| Open | High | Low | Volume | ||
| $15.11 | $15.21 | $14.95 | 4220 | ||
| Last updated 15.59pm 13/05/2024 ? | |||||
| CUV (ASX) Chart |